查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1492506

女性不孕症診斷和治療市場：按產品、治療、診斷、不孕原因和最終用戶 - 全球預測 2024-2030

Female Infertility Diagnosis & Treatment Market by Product (Accessories, Equipment, Media), Treatment (Assisted Reproductive Technology, Medication, Surgery), Diagnosis, Cause of Infertility, End User - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計2023年女性不孕症診斷與治療市場規模為18.1億美元，2024年達19.6億美元，2030年達31.4億美元，複合年成長率為8.11%。

女性不孕症的診斷和治療是全面性的，旨在解決與女性不孕症相關的原因和治療方法。診斷和治療解決方案是一體化的，從荷爾蒙評估和影像檢查到先進的輔助生殖技術 (ART)，包括體外受精 (IVF) 和手術干預。由於生活方式因素的變化，例如初為人母的老化、肥胖率上升以及包括多囊性卵巢症候群在內的相關健康狀況，女性不孕症發生率不斷上升，這增加了對女性不孕症診斷和治療的需求。此外，人們對不孕症問題的認知不斷提高，社會對接受治療的接受程度不斷提高，也支持了市場的成長。然而，由於ART和其他不孕症治療費用昂貴，女性不孕症診斷和治療的推廣受到限制。此外，人工智慧和機器學習在女性不孕症診斷和治療中的整合將提高診斷準確性、預測治療結果、提高整體治療效果並支持未來的成長。

主要市場統計
基準年[2023] 18.1億美元
預測年份 [2024] 19.6億美元
預測年份 [2030] 31.4億美元
複合年成長率（%） 8.11%

區域洞察

由於較高的消費者意識、強大的醫療基礎設施和有利的政府政策，美洲對不孕症治療的需求強烈。尤其是美國和加拿大，處於個人化醫療的前沿，正在大力投資相關研究，擴大創新治療方法選擇。由於人們認知的提高和醫療干預措施的可用性的增加，南美洲女性不孕症診斷和治療市場正在經歷顯著的市場開拓。歐洲擁有強大的醫療保健系統和法規，可確保較高的患者照護和資料安全標準，並為不孕症治療創造一個值得信賴的環境。在中東和非洲，不斷擴大的醫療保健投資以及擴大不孕症治療相關設施和服務是市場成長的驅動力。由於具有成本效益的治療和不斷提高的醫療水平，亞太地區已成為醫療旅遊中心。在中國和印度，消費者的需求是由成本、文化可接受性和技術可用性所驅動的。由於較高的收入水平和較高的意識，這些國家的都市區更有可能採用先進的醫療保健。

FPNV定位矩陣

FPNV定位矩陣對於評估供應商在女性不孕症診斷和治療市場的定位至關重要。此矩陣提供了對供應商的全面評估，並檢驗了與商務策略和產品滿意度相關的關鍵指標。這種詳細的評估使用戶能夠根據自己的要求做出明智的決定。根據評估，供應商被分為代表其成功程度的四個像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市場佔有率分析

市場佔有率分析是一種綜合工具，可以對女性不孕症診斷和治療市場中供應商的現狀進行深入而詳細的評估。透過仔細比較和分析供應商的貢獻，您可以更深入地了解每個供應商的績效以及他們在爭奪市場佔有率時面臨的挑戰。這些貢獻包括整體收益、客戶群和其他重要指標。此外，該分析還提供了對該行業競爭性質的寶貴見解，包括在研究基準年期間觀察到的累積、分散主導地位和合併特徵等因素。有了這些詳細資訊，供應商可以做出更明智的決策並製定有效的策略，以在市場競爭中保持領先地位。

策略分析與建議

策略分析對於尋求在全球市場站穩腳跟的組織至關重要。對目前在女性不孕症診斷和治療市場中的地位進行全面評估，使公司能夠做出符合其長期願望的明智決策。此關鍵評估涉及對組織的資源、能力和整體績效進行徹底分析，以確定核心優勢和需要改進的領域。

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 女性生殖和不孕問題增加
      • 政府促進獲得生殖保健解決方案的舉措
      • 生育診所正在世界各地擴張，提高了人們對生殖問題的認知。
    • 抑制因素
      • 缺乏熟練人員以及識別和治療不孕問題的複雜性
    • 機會
      • 持續創新，提高女性不孕症不孕診療方案的有效性和準確性
      • 對管理生殖問題的新創新和解決方案提供有利的監管支持
    • 任務
      • 對女性不孕症診斷和治療方案準確性和副作用的擔憂
  • 市場區隔分析
    • 產品：擴大支持胚胎體外生長和存活的培養基解決方案的引入
    • 最終使用者：生育診所專業生殖照護的首選
  • 市場擾動分析
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 價格分析
  • 技術分析
  • 專利分析
  • 貿易分析
  • 法規結構分析

第6章女性不孕診斷與治療市場：依產品

  • 配件
  • 裝置
  • 媒體

第7章依治療方式分類的女性不孕不孕診療市場

  • 輔助生殖技術
  • 藥物治療
  • 外科手術

第8章 女性不孕症診斷治療市場

  • 子宮鏡檢查
  • 影像檢查
  • 排卵測試

第9章 女性不孕不孕診療市場

  • 子宮內膜異位症
  • 排卵障礙
  • 輸卵管堵塞

第10章女性不孕症診斷與治療市場：依最終使用者分類

  • 不孕不育治療診所
  • 醫院
  • 調查機構

第11章美洲女性不孕診斷與治療市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第12章亞太地區女性不孕診斷與治療市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第13章歐洲、中東、非洲女性不孕不孕診療市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第14章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • 羽扇豆向美國市場推出新的非專利不孕症治療藥物
    • Arva Health 為印度女性提供創新的家庭不孕症測試
    • Trajan Scientific 和德國Start-UpsFertilly 在歐洲推出以微採樣為基礎的不孕症檢測套組
  • 戰略分析和建議

第15章競爭產品組合

  • 主要企業簡介
  • 主要產品系列
Product Code: MRR-FE70EC183B6E

[195 Pages Report] The Female Infertility Diagnosis & Treatment Market size was estimated at USD 1.81 billion in 2023 and expected to reach USD 1.96 billion in 2024, at a CAGR 8.11% to reach USD 3.14 billion by 2030.

The female infertility diagnosis & treatment are comprehensively structured to address the causes and treatments associated with infertility in women. It integrates diagnostic and therapeutic solutions, from hormonal assessments and imaging tests to advanced assisted reproductive technologies (ART), including in vitro fertilization (IVF) and surgical interventions. Increased infertility rates in females due to changes in lifestyle factors, such as higher age of first-time mothers, rising obesity rates, and associated health conditions, including PCOS, are raising the need for female infertility diagnosis & treatments. Moreover, growing awareness about fertility issues and greater social acceptance for seeking treatment support market growth. However, the high cost of ART and other infertility treatment limits patients to adopt female infertility diagnoses and treatments. Furthermore, the integration of AI and machine learning in female infertility diagnosis & treatment improves diagnostic accuracy and predict treatment outcomes, enhancing overall treatment efficacy and supporting future growth.

KEY MARKET STATISTICS
Base Year [2023] USD 1.81 billion
Estimated Year [2024] USD 1.96 billion
Forecast Year [2030] USD 3.14 billion
CAGR (%) 8.11%

Regional Insights

In the Americas, high consumer awareness, robust healthcare infrastructure, and favorable government policies drive a strong need for infertility treatments. The countries, notably the United States and Canada, are at the forefront of adopting personalized medicine approaches and investing heavily in related research, thus pushing the envelope in innovative treatment options. The South American market for female infertility diagnosis & treatment is undergoing notable development, driven by enhanced awareness and the increasing availability of medical interventions. Europe, with its robust healthcare systems and regulations, ensures high patient care and data safety standards, fostering a reliable environment for infertility treatments. In the Middle East and Africa, growing healthcare investments and enhancing facilities and services related to infertility treatments drive market growth. The Asia Pacific region is a hub for medical tourism due to cost-effective treatments and rising healthcare standards. In China and India, consumer needs are driven by cost, cultural acceptance, and technology availability. Urban areas in these countries show a higher propensity for adopting advanced medical treatments due to higher income levels and better awareness.

Market Insights

  • Market Dynamics

The market dynamics represent an ever-changing landscape of the Female Infertility Diagnosis & Treatment Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

    • Market Drivers
      • Rising prevalence of reproductive and fertility issues among women
      • Government initiatives to promote access to reproductive healthcare solutions
      • Expansion of fertility clinics across the world and expanding awareness about reproductive issues
    • Market Restraints
      • Lack of skilled personnel and complexity of identifying and treating fertility issues
    • Market Opportunities
      • Ongoing innovations to improve the effectiveness and accuracy of female infertility diagnosis and treatment solutions
      • Favorable regulatory support for new innovations and solutions for managing reproductive issues
    • Market Challenges
      • Concerns related to the accuracy and side effects of female infertility diagnosis and treatment solutions
  • Market Segmentation Analysis
    • Product: Increasing incorporation of media solutions as it support the growth and viability of embryos outside the body
    • End User: Fertility clinics' first-line choice for specialized reproductive care
  • Market Disruption Analysis
  • Porter's Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Female Infertility Diagnosis & Treatment Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Female Infertility Diagnosis & Treatment Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

Lupin Introduces New Generic Infertility Treatment in the U.S. Market

Lupin Limited announced the U.S. launch of its Ganirelix Acetate Injection, 250 mcg/0.5 mL, in a Single-Dose Prefilled Syringe, following the United States Food and Drug Administration (FDA) approval. This product is the generic version of Organon USA LLC's Ganirelix Acetate Injection and is designed to prevent premature luteinizing hormone rise in women undergoing controlled ovarian hyperstimulation. [Published On: 2024-02-16]

Arva Health's Innovative At-Home Fertility Test for Indian Women

Arva Health introduced an at-home fertility test developed with leading fertility experts. This test uniquely measures up to 12 hormonal levels pertinent to fertility, allowing women to conveniently assess their reproductive health from home. This is both cost-effective and non-intrusive compared to traditional clinic visits. Arva Health illuminates aspects of the biological clock and potential reproductive issues and equips women with the knowledge to manage their fertility journey proactively at their convenience and discretion. [Published On: 2023-12-13]

Trajan Scientific and German Startup Fertilly Introduce Microsampling-based Fertility Test Kits in Europe

Trajan Scientific and Medical partnered with Fertility to launch Europe's first-at-home fertility test kits. These kits incorporate advanced dried blood microsampling technology. Fertilly's move, supported by Trajan Scientific's innovative technologies, represents a crucial step towards democratizing fertility assessments and enabling more informed decisions regarding family planning. [Published On: 2023-08-15]

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Female Infertility Diagnosis & Treatment Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Female Infertility Diagnosis & Treatment Market, highlighting leading vendors and their innovative profiles. These include Bayer AG, Cook Group Incorporated, CooperSurgical Inc., Ferring B.V., FUJIFILM Irvine Scientific, Inc. by FUJIFILM Holdings Corporation, Genea Pty Limited, GlaxoSmithKline PLC, Halotech DNA S.L., Intas Pharmaceuticals Ltd., Lupin Limited, Merck & Co., Inc., Novartis AG, Sanofi SA, SCSA Diagnostics, Inc., Theramex by Kanga Health Ltd, and Vitrolife Sweden AB.

Market Segmentation & Coverage

This research report categorizes the Female Infertility Diagnosis & Treatment Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • Accessories
    • Equipment
    • Media
  • Treatment
    • Assisted Reproductive Technology
    • Medication
    • Surgery
  • Diagnosis
    • Hysteroscopy
    • Imaging Tests
    • Ovulation Testing
  • Cause of Infertility
    • Endometriosis
    • Ovulatory Disorders
    • Tubal Occlusion
  • End User
    • Fertility Clinics
    • Hospitals
    • Research Institutes
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of reproductive and fertility issues among women
      • 5.1.1.2. Government initiatives to promote access to reproductive healthcare solutions
      • 5.1.1.3. Expansion of fertility clinics across the world and expanding awareness about reproductive issues
    • 5.1.2. Restraints
      • 5.1.2.1. Lack of skilled personnel and complexity of identifying and treating fertility issues
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing innovations to improve the effectiveness and accuracy of female infertility diagnosis and treatment solutions
      • 5.1.3.2. Favorable regulatory support for new innovations and solutions for managing reproductive issues
    • 5.1.4. Challenges
      • 5.1.4.1. Concerns related to the accuracy and side effects of female infertility diagnosis and treatment solutions
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Increasing incorporation of media solutions as it support the growth and viability of embryos outside the body
    • 5.2.2. End User: Fertility clinics' first-line choice for specialized reproductive care
  • 5.3. Market Disruption Analysis
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Threat of New Entrants
    • 5.4.2. Threat of Substitutes
    • 5.4.3. Bargaining Power of Customers
    • 5.4.4. Bargaining Power of Suppliers
    • 5.4.5. Industry Rivalry
  • 5.5. Value Chain & Critical Path Analysis
  • 5.6. Pricing Analysis
  • 5.7. Technology Analysis
  • 5.8. Patent Analysis
  • 5.9. Trade Analysis
  • 5.10. Regulatory Framework Analysis

6. Female Infertility Diagnosis & Treatment Market, by Product

  • 6.1. Introduction
  • 6.2. Accessories
  • 6.3. Equipment
  • 6.4. Media

7. Female Infertility Diagnosis & Treatment Market, by Treatment

  • 7.1. Introduction
  • 7.2. Assisted Reproductive Technology
  • 7.3. Medication
  • 7.4. Surgery

8. Female Infertility Diagnosis & Treatment Market, by Diagnosis

  • 8.1. Introduction
  • 8.2. Hysteroscopy
  • 8.3. Imaging Tests
  • 8.4. Ovulation Testing

9. Female Infertility Diagnosis & Treatment Market, by Cause of Infertility

  • 9.1. Introduction
  • 9.2. Endometriosis
  • 9.3. Ovulatory Disorders
  • 9.4. Tubal Occlusion

10. Female Infertility Diagnosis & Treatment Market, by End User

  • 10.1. Introduction
  • 10.2. Fertility Clinics
  • 10.3. Hospitals
  • 10.4. Research Institutes

11. Americas Female Infertility Diagnosis & Treatment Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Female Infertility Diagnosis & Treatment Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Female Infertility Diagnosis & Treatment Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. Lupin Introduces New Generic Infertility Treatment in the U.S. Market
    • 14.3.2. Arva Health's Innovative At-Home Fertility Test for Indian Women
    • 14.3.3. Trajan Scientific and German Startup Fertilly Introduce Microsampling-based Fertility Test Kits in Europe
  • 14.4. Strategy Analysis & Recommendation

15. Competitive Portfolio

  • 15.1. Key Company Profiles
  • 15.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET RESEARCH PROCESS
  • FIGURE 2. FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET DYNAMICS
  • FIGURE 7. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2023 VS 2030 (%)
  • FIGURE 14. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 16. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. AMERICAS FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. AMERICAS FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. UNITED STATES FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 20. UNITED STATES FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. ASIA-PACIFIC FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. ASIA-PACIFIC FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 24. EUROPE, MIDDLE EAST & AFRICA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 25. FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 26. FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY ACCESSORIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY ACCESSORIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY EQUIPMENT, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY EQUIPMENT, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY MEDIA, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY MEDIA, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY MEDICATION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY MEDICATION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY SURGERY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY SURGERY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY HYSTEROSCOPY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY HYSTEROSCOPY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY IMAGING TESTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY IMAGING TESTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY OVULATION TESTING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY OVULATION TESTING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY ENDOMETRIOSIS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY ENDOMETRIOSIS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY OVULATORY DISORDERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY OVULATORY DISORDERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TUBAL OCCLUSION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TUBAL OCCLUSION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 39. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 40. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 41. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY FERTILITY CLINICS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 42. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY FERTILITY CLINICS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 43. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 44. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 45. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 46. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 47. AMERICAS FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 48. AMERICAS FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 49. AMERICAS FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 50. AMERICAS FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 51. AMERICAS FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
  • TABLE 52. AMERICAS FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
  • TABLE 53. AMERICAS FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2018-2023 (USD MILLION)
  • TABLE 54. AMERICAS FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2024-2030 (USD MILLION)
  • TABLE 55. AMERICAS FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 56. AMERICAS FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 57. AMERICAS FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 58. AMERICAS FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 59. ARGENTINA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 60. ARGENTINA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 61. ARGENTINA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 62. ARGENTINA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 63. ARGENTINA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
  • TABLE 64. ARGENTINA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
  • TABLE 65. ARGENTINA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2018-2023 (USD MILLION)
  • TABLE 66. ARGENTINA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2024-2030 (USD MILLION)
  • TABLE 67. ARGENTINA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 68. ARGENTINA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 69. BRAZIL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 70. BRAZIL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 71. BRAZIL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 72. BRAZIL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 73. BRAZIL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
  • TABLE 74. BRAZIL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
  • TABLE 75. BRAZIL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2018-2023 (USD MILLION)
  • TABLE 76. BRAZIL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2024-2030 (USD MILLION)
  • TABLE 77. BRAZIL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 78. BRAZIL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 79. CANADA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 80. CANADA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 81. CANADA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 82. CANADA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 83. CANADA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
  • TABLE 84. CANADA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
  • TABLE 85. CANADA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2018-2023 (USD MILLION)
  • TABLE 86. CANADA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2024-2030 (USD MILLION)
  • TABLE 87. CANADA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 88. CANADA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 89. MEXICO FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 90. MEXICO FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 91. MEXICO FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 92. MEXICO FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 93. MEXICO FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
  • TABLE 94. MEXICO FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
  • TABLE 95. MEXICO FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2018-2023 (USD MILLION)
  • TABLE 96. MEXICO FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2024-2030 (USD MILLION)
  • TABLE 97. MEXICO FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 98. MEXICO FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 99. UNITED STATES FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 100. UNITED STATES FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 101. UNITED STATES FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 102. UNITED STATES FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 103. UNITED STATES FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
  • TABLE 104. UNITED STATES FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
  • TABLE 105. UNITED STATES FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2018-2023 (USD MILLION)
  • TABLE 106. UNITED STATES FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2024-2030 (USD MILLION)
  • TABLE 107. UNITED STATES FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 108. UNITED STATES FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 109. UNITED STATES FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 110. UNITED STATES FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 111. ASIA-PACIFIC FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 112. ASIA-PACIFIC FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 113. ASIA-PACIFIC FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 114. ASIA-PACIFIC FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 115. ASIA-PACIFIC FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
  • TABLE 116. ASIA-PACIFIC FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
  • TABLE 117. ASIA-PACIFIC FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2018-2023 (USD MILLION)
  • TABLE 118. ASIA-PACIFIC FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2024-2030 (USD MILLION)
  • TABLE 119. ASIA-PACIFIC FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 120. ASIA-PACIFIC FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 121. ASIA-PACIFIC FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 122. ASIA-PACIFIC FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 123. AUSTRALIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 124. AUSTRALIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 125. AUSTRALIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 126. AUSTRALIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 127. AUSTRALIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
  • TABLE 128. AUSTRALIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
  • TABLE 129. AUSTRALIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2018-2023 (USD MILLION)
  • TABLE 130. AUSTRALIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2024-2030 (USD MILLION)
  • TABLE 131. AUSTRALIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 132. AUSTRALIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 133. CHINA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 134. CHINA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 135. CHINA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 136. CHINA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 137. CHINA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
  • TABLE 138. CHINA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
  • TABLE 139. CHINA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2018-2023 (USD MILLION)
  • TABLE 140. CHINA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2024-2030 (USD MILLION)
  • TABLE 141. CHINA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 142. CHINA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 143. INDIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 144. INDIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 145. INDIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 146. INDIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 147. INDIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
  • TABLE 148. INDIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
  • TABLE 149. INDIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2018-2023 (USD MILLION)
  • TABLE 150. INDIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2024-2030 (USD MILLION)
  • TABLE 151. INDIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 152. INDIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 153. INDONESIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 154. INDONESIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 155. INDONESIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 156. INDONESIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 157. INDONESIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
  • TABLE 158. INDONESIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
  • TABLE 159. INDONESIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2018-2023 (USD MILLION)
  • TABLE 160. INDONESIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2024-2030 (USD MILLION)
  • TABLE 161. INDONESIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 162. INDONESIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 163. JAPAN FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 164. JAPAN FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 165. JAPAN FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 166. JAPAN FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 167. JAPAN FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
  • TABLE 168. JAPAN FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
  • TABLE 169. JAPAN FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2018-2023 (USD MILLION)
  • TABLE 170. JAPAN FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2024-2030 (USD MILLION)
  • TABLE 171. JAPAN FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 172. JAPAN FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 173. MALAYSIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 174. MALAYSIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 175. MALAYSIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 176. MALAYSIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 177. MALAYSIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
  • TABLE 178. MALAYSIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
  • TABLE 179. MALAYSIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2018-2023 (USD MILLION)
  • TABLE 180. MALAYSIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2024-2030 (USD MILLION)
  • TABLE 181. MALAYSIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 182. MALAYSIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 183. PHILIPPINES FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 184. PHILIPPINES FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 185. PHILIPPINES FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 186. PHILIPPINES FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 187. PHILIPPINES FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
  • TABLE 188. PHILIPPINES FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
  • TABLE 189. PHILIPPINES FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2018-2023 (USD MILLION)
  • TABLE 190. PHILIPPINES FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2024-2030 (USD MILLION)
  • TABLE 191. PHILIPPINES FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 192. PHILIPPINES FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 193. SINGAPORE FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 194. SINGAPORE FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 195. SINGAPORE FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 196. SINGAPORE FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 197. SINGAPORE FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
  • TABLE 198. SINGAPORE FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
  • TABLE 199. SINGAPORE FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2018-2023 (USD MILLION)
  • TABLE 200. SINGAPORE FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2024-2030 (USD MILLION)
  • TABLE 201. SINGAPORE FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 202. SINGAPORE FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 203. SOUTH KOREA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 204. SOUTH KOREA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 205. SOUTH KOREA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 206. SOUTH KOREA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 207. SOUTH KOREA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
  • TABLE 208. SOUTH KOREA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
  • TABLE 209. SOUTH KOREA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2018-2023 (USD MILLION)
  • TABLE 210. SOUTH KOREA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2024-2030 (USD MILLION)
  • TABLE 211. SOUTH KOREA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 212. SOUTH KOREA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 213. TAIWAN FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 214. TAIWAN FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 215. TAIWAN FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 216. TAIWAN FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 217. TAIWAN FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
  • TABLE 218. TAIWAN FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
  • TABLE 219. TAIWAN FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2018-2023 (USD MILLION)
  • TABLE 220. TAIWAN FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2024-2030 (USD MILLION)
  • TABLE 221. TAIWAN FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 222. TAIWAN FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 223. THAILAND FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 224. THAILAND FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 225. THAILAND FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 226. THAILAND FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 227. THAILAND FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
  • TABLE 228. THAILAND FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
  • TABLE 229. THAILAND FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2018-2023 (USD MILLION)
  • TABLE 230. THAILAND FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2024-2030 (USD MILLION)
  • TABLE 231. THAILAND FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 232. THAILAND FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 233. VIETNAM FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 234. VIETNAM FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 235. VIETNAM FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 236. VIETNAM FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 237. VIETNAM FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
  • TABLE 238. VIETNAM FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
  • TABLE 239. VIETNAM FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2018-2023 (USD MILLION)
  • TABLE 240. VIETNAM FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2024-2030 (USD MILLION)
  • TABLE 241. VIETNAM FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 242. VIETNAM FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 243. EUROPE, MIDDLE EAST & AFRICA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 244. EUROPE, MIDDLE EAST & AFRICA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 245. EUROPE, MIDDLE EAST & AFRICA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 246. EUROPE, MIDDLE EAST & AFRICA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 247. EUROPE, MIDDLE EAST & AFRICA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
  • TABLE 248. EUROPE, MIDDLE EAST & AFRICA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
  • TABLE 249. EUROPE, MIDDLE EAST & AFRICA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2018-2023 (USD MILLION)
  • TABLE 250. EUROPE, MIDDLE EAST & AFRICA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2024-2030 (USD MILLION)
  • TABLE 251. EUROPE, MIDDLE EAST & AFRICA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 252. EUROPE, MIDDLE EAST & AFRICA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 253. EUROPE, MIDDLE EAST & AFRICA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 254. EUROPE, MIDDLE EAST & AFRICA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 255. DENMARK FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 256. DENMARK FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 257. DENMARK FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 258. DENMARK FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 259. DENMARK FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
  • TABLE 260. DENMARK FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
  • TABLE 261. DENMARK FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2018-2023 (USD MILLION)
  • TABLE 262. DENMARK FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2024-2030 (USD MILLION)
  • TABLE 263. DENMARK FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 264. DENMARK FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 265. EGYPT FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 266. EGYPT FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 267. EGYPT FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 268. EGYPT FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 269. EGYPT FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
  • TABLE 270. EGYPT FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
  • TABLE 271. EGYPT FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2018-2023 (USD MILLION)
  • TABLE 272. EGYPT FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2024-2030 (USD MILLION)
  • TABLE 273. EGYPT FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 274. EGYPT FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 275. FINLAND FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 276. FINLAND FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 277. FINLAND FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 278. FINLAND FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 279. FINLAND FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
  • TABLE 280. FINLAND FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
  • TABLE 281. FINLAND FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2018-2023 (USD MILLION)
  • TABLE 282. FINLAND FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2024-2030 (USD MILLION)
  • TABLE 283. FINLAND FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 284. FINLAND FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 285. FRANCE FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 286. FRANCE FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLIO